LinusBio develops precision exposome biomarkers by sequencing temporal molecular features from hair samples. This proprietary platform utilizes robotics, mass spectrometry, and AI to generate comprehensive physiological data over time. The resulting biomarkers support earlier disease diagnosis, patient monitoring, and accelerated drug development across CNS disorders and other conditions.
Funding
$31.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current diagnostic methods for complex conditions, particularly central nervous system (CNS) and gastrointestinal (GI) disorders, often lack objective biological tests, hindering accurate and timely diagnoses. This absence of reliable biomarkers leaves many patients without clear answers or targeted treatment plans.
Solution
LinusBio offers a precision medicine approach that uses temporal exposome sequencing to analyze an individual's unique biological response to environmental exposures over time. Their platform uses hair samples to map these molecular patterns, creating a time-dependent view of human physiology. By comparing these molecular signatures to a global patient dataset, LinusBio identifies novel biomarkers for health and disease, particularly for conditions lacking traditional diagnostic methods. This technology aims to deliver on the promise of precision medicine for patients with CNS and GI disorders.
Target Audience
The primary target audience includes healthcare providers and families seeking improved diagnostic tools for complex conditions like Autism Spectrum Disorder, as well as researchers and clinicians focused on CNS and GI disorders.
Features
- Temporal exposomic sequencing platform analyzes the molecular effects of environmental exposures using hair samples.
- Cutting-edge data science compares molecular signatures to a global patient dataset.
- Identification of novel biomarkers for complex conditions, such as CNS and GI disorders.
- StrandDx™ASD: A non-invasive diagnostic aid for Autism Spectrum Disorder.